An investigation of three injections techniques in reducing local injection pain with a human papillomavirus vaccine: A randomized trial

Vaccine

Volumn 31, Issue 8, 2013, Pages 1157-1162

  Petousis Harris, Helen ^a   Poole, Tracey ^a   Stewart, Joanna ^a   Turner, Nikki ^a   Goodyear Smith, Felicity ^a   Coster, Gregor ^a   Lennon, Diana ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Human papillomavirus vaccine L1; Immune system processes; Injections; Intramuscular; Patient safety; Type 6, 11, 16, 18; Vaccination

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE PAIN; INJECTION SITE SWELLING; MALE; MEDICAL HISTORY; NORMAL HUMAN; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOCIAL SUPPORT; STRESS; VACCINATION; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; CROSS-OVER STUDIES; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; INJECTIONS; MALE; MIDDLE AGED; PAIN; PAPILLOMAVIRUS VACCINES; YOUNG ADULT;

EID: 84873096509     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.12.064     Document Type: Article

References (28)

1. Gidudu J., Kohl K.S., Halperin S., Hammer S.J., Heath P.T., Hennig R., et al. A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2008, 26(52):6800-6813.
2. Kohl K.S., Walop W., Gidudu J., Ball L., Halperin S., Hammer S.J., et al. Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2007, 25(31):5839-5857.
3. Kohl K.S., Walop W., Gidudu J., Ball L., Halperin S., Hammer S.J., et al. Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data. Vaccine 2007, 25(31):5858-5874.
4. Petousis-Harris H. Vaccine injection technique and reactogenicity - evidence for practice. Vaccine 2008, 26:6299-6304.
5. Christy C., Pichichero M.E., Reed G.F., Decker M.D., Anderson E.L., Rennels M.B., et al. Effect of gender, race, and parental education on immunogenicity and reported reactogenicity of acellular and whole-cell pertussis vaccines. Pediatrics 1995, 96(3):584-587.
6. Pittman P.R., Gibbs P.H., Cannon T.L., Friedlander A.M. Anthrax vaccine: short-term safety experience in humans. Vaccine 2001, 20(5-6):972-978.
7. Mark A., Carlsson R.M., Granstrom M. Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents. Vaccine 1999, 17(15-16):2067-2072.
8. Jackson L.A., Austin G., Chen R.T., Stout R., DeStefano F., Gorse G.J., et al. Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors. Vaccine 2001, 19(32):4703-4709.
9. Beyer W.E., Palache A.M., Kerstens R., Masurel N. Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies. Eur J Clin Microbiol Infect Dis 1996, 15(1):65-70.
10. Shohat T., Green M.S., Nakar O., Ballin A., Duvdevani P., Cohen A., et al. Gender differences in the reactogenicity of measles-mumps-rubella vaccine. Isr Med Assoc J 2000, 2(3):192-195.
11. Pittman P.R. Aluminum-containing vaccine associated adverse events: role of route of administration and gender. Vaccine 2002, 20(Suppl. 3):S48-S50.
12. Khalil M.K., Al-Mazrou Y.Y., Al-Ghamdi Y.S., Tumsah S., Al-Jeffri M., Meshkhas A. Effect of gender on reporting of MMR adverse events in Saudi Arabia. East Mediterr Health J 2003, 9(1-2):152-158.
13. Block S.L., Nolan T., Sattler C., Barr E., Giacoletti K.E.D., Marchant C.D., et al. Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics 2006, 118(5):2135-2145.
14. Segerstrom S.C., Miller G.E. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull 2004, 130(4):601-630.
15. Dhabhar F.S. Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. Neuroimmune biology 2007, 207-224. Elsevier. G.P.C. Adriana del Rey, O.B. Hugo (Eds.).
16. Food and Drug Administration. Clinical Review of Biologics License Application for Human Papillomavirus 6, 11, 16, 18 L1 Virus Like Particle Vaccine (S. cerevisiae) (STN 125126 GARDASIL), Manufactured by Merck, Inc, Division of Vaccines and Related Products Applications. Vaccines Clinical Trial Branch, Office of Vaccines Research and Review, Centre for Biologics Evaluation and Research, Food and Drug Administration, Silverspring, MD, 2006, p. 2.
17. Ipp M., Taddio A., Sam J., Gladbach M., Parkin P.C. Vaccine-related pain: randomised controlled trial of two injection techniques. Arch Dis Child 2007, 92(12):1105-1108.
18. Sheldon C., Kamarck T., Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983, 24(4):385-396.
19. Taddio A., Appleton M., Bortolussi R., Chambers C., Dubey V., Halperin S., et al. Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline. Can Med Assoc J 2010, 182(18):E843-E855.
20. McGarvey M.A., Hooper A.C.B. The deltoid intramuscular injection site in the adult. Current practice among general practitioners and practice nurses. Ir Med J 2005, 98(4):105-107.
21. Kontakis G.M., Steriopoulos K., Damilakis J., Michalodimitrakis E. The position of the axillary nerve in the deltoid muscle: a cadaveric study. Acta Orthop 1999, 70(1):9-11.
22. Loukas M., Grabska J., Tubbs R., Apaydin N., Jordan R. Mapping the axillary nerve within the deltoid muscle. Surg Radiol Anat 2009, 31(1):43-47.
23. Davidson L.T.M.D, Carter G.T.M.D., Kilmer D.D.M.D., Han J.J.M.D. Iatrogenic axillary neuropathy after intramuscular injection of the deltoid muscle. Am J Phys Med Rehabil 2007, 86(6):507-511.
24. Cook I.F. An evidence based protocol for the prevention of upper arm injury related to vaccine administration (UAIRVA). Hum Vaccin 2011, 7(8):845-848.
25. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., Unger E.R., et al. Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). Morb Mortal Wkly Rep Recomm Rep 2007, 56(RR-2):1-24.
26. Fish E.N. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol 2008, 8(9):737-744.
27. Rettew J.A., Huet-Hudson Y.M., Marriott I. Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity. Biol Reprod 2008, 78(3):432-437.
28. Cohen S. Social relationships and health. Am Psychol 2004, 59(8):676-684.